|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 10/27/17 Anika Therapeutics, Inc. 10-Q 9/30/17 66:4.1M Globenewswire Inc./FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 218K
2: EX-10.1 Material Contract HTML 882K
3: EX-10.2 Material Contract HTML 128K
4: EX-31.1 Certification -- §302 - SOA'02 HTML 24K
5: EX-31.2 Certification -- §302 - SOA'02 HTML 24K
6: EX-32.1 Certification -- §906 - SOA'02 HTML 19K
13: R1 Document And Entity Information HTML 46K
14: R2 Condensed Consolidated Balance Sheets (Current HTML 90K
Period Unaudited)
15: R3 Condensed Consolidated Balance Sheets (Current HTML 39K
Period Unaudited) (Parentheticals)
16: R4 Condensed Consolidated Statements of Operations HTML 75K
and Comprehensive Income (Unaudited)
17: R5 Condensed Consolidated Statements of Cash Flows HTML 96K
(Unaudited)
18: R6 Note 1 - Nature of Business HTML 24K
19: R7 Note 2 - Basis of Presentation HTML 28K
20: R8 Note 3 - Recent Accounting Pronouncements HTML 37K
21: R9 Note 4 - Investments HTML 24K
22: R10 Note 5 - Fair Value Measurements HTML 42K
23: R11 Note 6 - Equity Incentive Plan HTML 46K
24: R12 Note 7 - Earnings Per Share ("Eps") HTML 36K
25: R13 Note 8 - Inventories HTML 25K
26: R14 Note 9 - Intangible Assets HTML 38K
27: R15 Note 10 - Goodwill HTML 25K
28: R16 Note 11 - Accrued Expenses HTML 27K
29: R17 Note 12 - Commitments and Contingencies HTML 26K
30: R18 Note 13 - Leases HTML 26K
31: R19 Note 14 - Income Taxes HTML 30K
32: R20 Note 15 - Depuy Synthes Mitek Sports Medicine HTML 25K
Agreements
33: R21 Note 16 - Segment and Geographic Information HTML 46K
34: R22 Note 17 - Subsequent Event HTML 26K
35: R23 Note 5 - Fair Value Measurements (Tables) HTML 38K
36: R24 Note 6 - Equity Incentive Plan (Tables) HTML 36K
37: R25 Note 7 - Earnings Per Share ("Eps") (Tables) HTML 27K
38: R26 Note 8 - Inventories (Tables) HTML 26K
39: R27 Note 9 - Intangible Assets (Tables) HTML 32K
40: R28 Note 10 - Goodwill (Tables) HTML 24K
41: R29 Note 11 - Accrued Expenses (Tables) HTML 26K
42: R30 Note 16 - Segment and Geographic Information HTML 47K
(Tables)
43: R31 Note 3 - Recent Accounting Pronouncements (Details HTML 22K
Textual)
44: R32 Note 4 - Investments (Details Textual) HTML 24K
45: R33 Note 5 - Fair Value Measurements - Fair Value of HTML 37K
Financial Instruments (Details)
46: R34 Note 6 - Equity Incentive Plan (Details Textual) HTML 49K
47: R35 Note 6 - Equity Incentive Plan - Assumptions Used HTML 32K
to Estimate Fair Value of Stock Options and Stock
Appreciation Rights (Details)
48: R36 Note 6 - Equity Incentive Plan - Total Stock-based HTML 27K
Compensation Expense (Details)
49: R37 Note 7 - Earnings Per Share ("Eps") (Details HTML 42K
Textual)
50: R38 Note 7 - Earnings Per Share ("EPS") - Basic and HTML 28K
Diluted Earnings Per Share (Details)
51: R39 Note 8 - Inventories - Summary of Inventories HTML 29K
(Details)
52: R40 Note 9 - Intangible Assets (Details Textual) HTML 21K
53: R41 Note 9 - Intangible Assets - Summary of Intangible HTML 43K
Assets (Details)
54: R42 Note 10 - Goodwill - Changes in the Carrying Value HTML 23K
of Goodwill (Details)
55: R43 Note 11 - Accrued Expenses - Summary of Accrued HTML 38K
Expenses (Details)
56: R44 Note 12 - Commitments and Contingencies (Details HTML 20K
Textual)
57: R45 Note 13 - Leases (Details Textual) HTML 38K
58: R46 Note 14 - Income Taxes (Details Textual) HTML 34K
59: R47 Note 15 - Depuy Synthes Mitek Sports Medicine HTML 28K
Agreements (Details Textual)
60: R48 Note 16 - Segment and Geographic Information HTML 19K
(Details Textual)
61: R49 Note 16 - Segment and Geographic Information - HTML 27K
Product Revenue by Product Group (Details)
62: R50 Note 16 - Segment and Geographic Information - HTML 29K
Total Revenue by Geographic Location (Details)
63: R51 Note 17 - Subsequent Event (Details Textual) HTML 38K
65: XML IDEA XML File -- Filing Summary XML 113K
64: EXCEL IDEA Workbook of Financial Reports XLSX 48K
7: EX-101.INS XBRL Instance -- anik-20170930 XML 770K
9: EX-101.CAL XBRL Calculations -- anik-20170930_cal XML 100K
10: EX-101.DEF XBRL Definitions -- anik-20170930_def XML 795K
11: EX-101.LAB XBRL Labels -- anik-20170930_lab XML 603K
12: EX-101.PRE XBRL Presentations -- anik-20170930_pre XML 810K
8: EX-101.SCH XBRL Schema -- anik-20170930 XSD 130K
66: ZIP XBRL Zipped Folder -- 0001171843-17-006367-xbrl Zip 86K
 | Download this zipped .zip folder |
| Files: | anik-20170930.xml anik-20170930.xsd anik-20170930_cal.xml anik-20170930_def.xml anik-20170930_lab.xml anik-20170930_pre.xml |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/15/24 Anika Therapeutics, Inc. 10-K 12/31/23 90:9.1M Globenewswire Inc./FA 3/16/23 Anika Therapeutics, Inc. 10-K 12/31/22 97:10M Globenewswire Inc./FA 3/11/22 Anika Therapeutics, Inc. 10-K 12/31/21 105:25M Globenewswire Inc./FA 4/26/21 Anika Therapeutics, Inc. 10-K/A 12/31/20 100:10M Globenewswire Inc./FA 3/05/21 Anika Therapeutics, Inc. 10-K 12/31/20 105:11M Globenewswire Inc./FA |